HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kandai Nozu Selected Research

Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)

5/2018Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndrome.
4/2006EYA1 and SIX1 gene mutations in Japanese patients with branchio-oto-renal (BOR) syndrome and related conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kandai Nozu Research Topics

Disease

28Nephrotic Syndrome (Syndrome, Nephrotic)
02/2022 - 05/2002
22Hereditary Nephritis (Alport Syndrome)
01/2022 - 12/2006
20Proteinuria
05/2022 - 02/2004
12IGA Glomerulonephritis (IGA Nephropathy)
06/2022 - 02/2004
11Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 04/2011
8Gitelman Syndrome
09/2022 - 04/2007
6Kidney Diseases (Kidney Disease)
07/2022 - 05/2009
6Seizures (Absence Seizure)
03/2022 - 07/2019
6Infections
01/2022 - 02/2008
6Glomerulonephritis
11/2020 - 05/2009
5Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
03/2022 - 03/2008
5Status Epilepticus (Complex Partial Status Epilepticus)
03/2022 - 01/2018
5Bartter Syndrome (Syndrome, Bartter)
10/2021 - 09/2007
4Inborn Genetic Diseases (Disease, Hereditary)
03/2022 - 12/2017
4Hypotension (Low Blood Pressure)
02/2022 - 01/2020
4Renal Insufficiency (Renal Failure)
12/2020 - 08/2004
4Hemolytic-Uremic Syndrome
01/2020 - 08/2004
4Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2020 - 02/2006
4Acute Kidney Injury (Acute Renal Failure)
12/2016 - 12/2009
3Fabry Disease (Fabry's Disease)
12/2022 - 11/2021
3Brain Diseases (Brain Disorder)
03/2022 - 05/2021
3Disease Progression
02/2022 - 05/2020
3Nephritis
01/2022 - 05/2009
3Nephrocalcinosis
12/2020 - 08/2007
3Alkalosis
04/2020 - 01/2011
3Hypokalemia
04/2020 - 04/2016
3Wilms Tumor (Wilm's Tumor)
01/2020 - 06/2012
3Epilepsy (Aura)
01/2019 - 10/2014
3Sclerosis
11/2018 - 06/2012
2Sepsis (Septicemia)
12/2022 - 06/2009
2Coma (Comas)
03/2022 - 11/2018
2Fever (Fevers)
03/2022 - 08/2019
2Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 01/2021
2Hemorrhagic shock and encephalopathy syndrome
03/2022 - 01/2021
2Purpura
01/2022 - 05/2009
2Hypertension (High Blood Pressure)
11/2021 - 01/2020
2Fibrosis (Cirrhosis)
01/2021 - 05/2009
2Pierson syndrome
01/2021 - 10/2018
2Pseudohypoaldosteronism
01/2021 - 11/2009
2Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
11/2020 - 01/2020
2Membranous Glomerulonephritis (Membranous Nephropathy)
01/2020 - 03/2009
2Polycystic Kidney Diseases (Polycystic Kidney Disease)
10/2019 - 12/2012
2Cakut
09/2019 - 06/2010
2Shock
09/2019 - 08/2019
2Hypocalcemia
07/2019 - 04/2016

Drug/Important Bio-Agent (IBA)

16Rituximab (Mabthera)FDA Link
01/2022 - 11/2005
15SteroidsIBA
07/2021 - 05/2002
11Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2006
10Collagen Type IV (Type IV Collagen)IBA
12/2020 - 08/2008
7SaltsIBA
09/2022 - 10/2009
7Immunoglobulin A (IgA)IBA
07/2021 - 06/2008
6CollagenIBA
03/2022 - 05/2014
6Monoclonal AntibodiesIBA
07/2021 - 03/2008
6Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2016 - 05/2002
4CreatinineIBA
05/2022 - 11/2018
4Anticonvulsants (Antiepileptic Drugs)IBA
03/2022 - 01/2018
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2019 - 12/2006
4Prednisolone (Predate)FDA LinkGeneric
11/2018 - 01/2011
3GalactosidasesIBA
12/2022 - 11/2021
3barbituric acid (barbiturate)IBA
03/2022 - 11/2018
3EnzymesIBA
03/2022 - 05/2009
3DNA (Deoxyribonucleic Acid)IBA
02/2022 - 04/2006
3Messenger RNA (mRNA)IBA
01/2022 - 04/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 02/2006
3AntigensIBA
10/2021 - 03/2009
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2021 - 08/2019
3Furosemide (Lasix)FDA LinkGeneric
01/2021 - 12/2010
3PotassiumIBA
12/2020 - 08/2007
3Lisinopril (Prinivil)FDA LinkGeneric
11/2020 - 12/2006
3mizoribineIBA
11/2018 - 04/2006
3NucleotidesIBA
10/2015 - 04/2007
2ChloridesIBA
09/2022 - 12/2010
2Hepatocyte Nuclear FactorsIBA
07/2022 - 09/2019
2fosphenytoin (Cerebyx)FDA LinkGeneric
03/2022 - 11/2018
2BenzodiazepinesIBA
03/2022 - 08/2020
2Mitochondrial DNA (mtDNA)IBA
03/2022 - 01/2021
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2022 - 11/2018
2RNA (Ribonucleic Acid)IBA
11/2021 - 05/2018
2galactosyl-deficient IgA1IBA
07/2021 - 01/2020
2ThiazidesIBA
01/2021 - 12/2010
2Laminin (Merosin)IBA
01/2021 - 10/2018
2CytokinesIBA
01/2021 - 08/2004
2Cadherins (E-Cadherin)IBA
01/2021 - 02/2011
2DiureticsIBA
01/2021 - 04/2016
2SodiumIBA
12/2020 - 01/2011
2Uric Acid (Urate)IBA
12/2020 - 12/2009
2ReninIBA
12/2020 - 01/2020
2dirhodium tetraacetate (DRTA)IBA
11/2020 - 12/2017
2RNA Splice SitesIBA
01/2020 - 11/2014
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 04/2017
2Antigen-Antibody Complex (Immune Complex)IBA
01/2020 - 03/2009
2ElectrolytesIBA
09/2019 - 07/2019
2MethylprednisoloneFDA LinkGeneric
08/2019 - 03/2008
2Parathyroid Hormone (Parathormone)IBA
07/2019 - 04/2016

Therapy/Procedure

35Therapeutics
06/2022 - 12/2006
5Nephrectomy
02/2022 - 06/2012
4Kidney Transplantation
11/2021 - 11/2005
3Renal Dialysis (Hemodialysis)
12/2022 - 07/2018
3Aftercare (After-Treatment)
01/2022 - 01/2017
3Ligation
11/2020 - 09/2009